These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 33092994)
1. A new 7-point method facilitates accurate diagnosis of high-grade urothelial carcinoma in routine urinary cytology practice. Iwai S; Mimura A; Ohtani H; Shimokama T; Kinjo M J Am Soc Cytopathol; 2021; 10(1):103-109. PubMed ID: 33092994 [TBL] [Abstract][Full Text] [Related]
2. Cyto-histo correlations of plasmacytoid and micropapillary variants of high-grade urothelial carcinoma: do they fit well in The Paris System for reporting urinary cytology? Suo L; Vega I; Thrall M J Am Soc Cytopathol; 2021; 10(1):20-24. PubMed ID: 32620533 [TBL] [Abstract][Full Text] [Related]
3. Urinary tract cytology: a cytologic-histopathologic correlation with The Paris System, an institutional study. Danakas A; Sweeney M; Cheris S; Agrawal T J Am Soc Cytopathol; 2021; 10(1):56-63. PubMed ID: 33132054 [TBL] [Abstract][Full Text] [Related]
4. Evidence-based diagnostic accuracy measurement in urine cytology using likelihood ratios. Myles N; Auger M; Kanber Y; Caglar D; Kassouf W; Brimo F J Am Soc Cytopathol; 2021; 10(1):71-78. PubMed ID: 33071190 [TBL] [Abstract][Full Text] [Related]
5. The Paris System for Reporting Urinary Cytology reduces atypia rates and does not alter the negative predictive value of urine cytology. McIntire PJ; Kilic I; Pambuccian SE; Wojcik EM; Barkan GA J Am Soc Cytopathol; 2021; 10(1):14-19. PubMed ID: 33221245 [TBL] [Abstract][Full Text] [Related]
6. An institutional experience evaluating hTERT immunostaining in 100 consecutive ThinPrep urine specimens. Xing J; Han M; Monaco SE; Dhir R; Roy S; Pantanowitz L J Am Soc Cytopathol; 2021; 10(1):88-93. PubMed ID: 32354607 [TBL] [Abstract][Full Text] [Related]
7. The Paris System for reporting urinary cytology in daily practice with emphasis on ancillary testing by multiprobe FISH. Vlajnic T; Gut A; Savic S; Bubendorf L J Clin Pathol; 2020 Feb; 73(2):90-95. PubMed ID: 31467041 [TBL] [Abstract][Full Text] [Related]
8. The Paris System "atypical urothelial cells" category: can the current criteria be improved? Vosoughi A; Ordobazari A; Lora Gonzalez MA; Guido LP; Skiba M; Campuzano-Zuluaga G; Kryvenko ON; Gomez-Fernandez C; Garcia-Buitrago M; Jorda M J Am Soc Cytopathol; 2021; 10(1):3-8. PubMed ID: 32732113 [TBL] [Abstract][Full Text] [Related]
9. Experience on the use of The Paris System for Reporting Urinary Cytopathology: review of the published literature. Pastorello RG; Barkan GA; Saieg M J Am Soc Cytopathol; 2021; 10(1):79-87. PubMed ID: 33160893 [TBL] [Abstract][Full Text] [Related]
10. High-grade urothelial carcinoma in urine cytology: different spaces - different faces, highlighting morphologic variance. McIntire PJ; Elsoukkary SS; Robinson BD; Siddiqui MT J Am Soc Cytopathol; 2021; 10(1):36-40. PubMed ID: 32958411 [TBL] [Abstract][Full Text] [Related]
11. The Paris System for urine cytology in upper tract urothelial specimens: A comparative analysis with biopsy and surgical resection. Zheng X; Si Q; Du D; Harshan M; Zhang Z; Haines K; Shi W; Chhieng DC Cytopathology; 2018 Apr; 29(2):184-188. PubMed ID: 29251368 [TBL] [Abstract][Full Text] [Related]
12. [A real-world study of the clinical application of the Paris system for reporting urinary cytology in cancer hospital]. Zhao H; Zhang ZH; Guo HQ; Wei N; Ma HY; Zhao LL; Sun Y; Wang C; Chang XX; Bi XG; Xing NZ Zhonghua Zhong Liu Za Zhi; 2024 Jul; 46(7):703-709. PubMed ID: 39034806 [No Abstract] [Full Text] [Related]
13. A review of urinary cytology in the setting of upper tract urothelial carcinoma. Zhang ML; VandenBussche CJ; Hang JF; Miki Y; McIntire PJ; Peyton S; Vohra P J Am Soc Cytopathol; 2021; 10(1):29-35. PubMed ID: 32792229 [TBL] [Abstract][Full Text] [Related]
14. Split-sample comparison of urothelial cells in ThinPrep and cytospin preparations in urinary cytology: Do we need to adjust The Paris System for Reporting Urinary Cytology criteria? Richardson CJ; Pambuccian SE; Barkan GA Cancer Cytopathol; 2020 Feb; 128(2):119-125. PubMed ID: 31774630 [TBL] [Abstract][Full Text] [Related]
15. Outcome analysis and negative predictive value of the "unsatisfactory/nondiagnostic" category of The Paris System for Reporting Urinary Cytology. Abro S; Nomani L; Wojcik EM; Pambuccian SE; Chatt G; Barkan GA J Am Soc Cytopathol; 2021; 10(1):64-70. PubMed ID: 33279453 [TBL] [Abstract][Full Text] [Related]
16. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology. Roy M; Kaushal S; Jain D; Seth A; Iyer VK; Mathur SR Cytopathology; 2017 Dec; 28(6):509-515. PubMed ID: 28833848 [TBL] [Abstract][Full Text] [Related]
17. High-grade urothelial carcinoma with hypochromatic chromatin in urine cytology. Renshaw AA; Gould EW J Am Soc Cytopathol; 2021; 10(1):25-28. PubMed ID: 33132055 [TBL] [Abstract][Full Text] [Related]
18. Causes of false-negative for high-grade urothelial carcinoma in urine cytology. Lee PJ; Owens CL; Lithgow MY; Jiang Z; Fischer AH Diagn Cytopathol; 2016 Dec; 44(12):994-999. PubMed ID: 27781412 [TBL] [Abstract][Full Text] [Related]
19. Cytohistological correlation of urine cytology in a tertiary centre with application of the Paris system. Rohilla M; Singh P; Rajwanshi A; Gupta N; Srinivasan R; Dey P; Kakkar N Cytopathology; 2018 Oct; 29(5):436-443. PubMed ID: 29920811 [TBL] [Abstract][Full Text] [Related]
20. Developing a Machine Learning Algorithm for Identifying Abnormal Urothelial Cells: A Feasibility Study. Zhang Z; Fu X; Liu J; Huang Z; Liu N; Fang F; Rao J Acta Cytol; 2021; 65(4):335-341. PubMed ID: 33022673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]